FOA Title: 
Notice of Intent to Publish a Funding Opportunity Announcement for The National Drug Abuse Treatment Clinical Trials Network (UG1) Clinical Trial Optional
Grant Type: 
Primary IC: 
Release Date: 
Jul 11 2018
Expiration Date: 
AC Source: 
Notice Intent Publish Funding Opportunity Announcement The National Drug Abuse Treatment Clinical Trials Network UG1) Clinical Trial Optional Notice Number: NOT-DA-18-024 Key Dates Release Date: July 11, 2018 Estimated Publication Date Funding Opportunity Announcement: July 28, 2018 First Estimated Application Due Date: November 01, 2018 Earliest Estimated Award Date: June 01, 2019 Earliest Estimated Start Date: July 01, 2019 Related Announcements NOT-OD-18-181 Issued National Institute Drug Abuse NIDA) Purpose National Institute Drug Abuse NIDA) intends publish Funding Opportunity Announcement FOA) solicit applications clinical investigators participate the National Drug Abuse Treatment Clinical Trials Network CTN). The ongoing opioid epidemic overdose death crisis present urgent public health need quickly expand CTN 1) increase Network’s scientific clinical research capabilities, 2) better cover geographic regions across United States regions most impacted the opioid overdose epidemic. CTN expansion part the NIH Helping End Addiction Long-Term HEAL) Initiative. purpose this notice to allow potential applicants sufficient time develop meaningful collaborations projects.  FOA expected be published August 2018 an expected application due date November 2018. FOA utilize UG1 activity code. Research Initiative Details CTN currently comprised 13 research Nodes serve research training centers, numerous collaborating healthcare organizations clinical research sites, two coordinating centers. CTN program administered within NIDA through Center the Clinical Trials Network CCTN). The ongoing opioid epidemic overdose death crisis present critical public health need expeditiously augment CTN research portfolio enhance treatment options improve quality opioid disorder OUD) treatment. NIDA decided expand CTN infrastructure research portfolio address enhance every stage the cascade care OUD. includes screening diagnosis OUD among those affected; linkage care among those diagnosed OUD; opioid agonist, partial agonist, antagonist medication initiation among those entering care; retention at least six months among those initiate medication; relapse prevention remission among those retained care. Research prevention early intervention unhealthy opioid use/misuse also high priority. Research prevention reversal opioid overdose the community emergency departments another priority. expansion enhance CTN’s ability use cutting-edge research designs, methods, data resources. example, addition Nodes expertise clinical data science informatics bolster CTN’s capacity conduct pragmatic studies embedded clinical practice will inform care. Additional Nodes located geographic regions severely affected the opioid epidemic allow greater reach impact research across country. mentioned in NOT-OD-18-181, any for-profit recipient funds shall subject a matching requirement funds documented in-kind contributions not less 50 percent the total funds awarded such entity. funding opportunity being offered part the NIH’s Helping End Addiction Long-term HEAL) initiative speed scientific solutions the national opioid public health crisis. NIH HEAL Initiative bolster research across NIH 1) improve treatment opioid misuse addiction 2) enhance pain management. information the HEAL Initiative available at: Funding Information Estimated Total Funding TBD Expected Number Awards TBD Estimated Award Ceiling TBD Primary CFDA Numbers TBD Anticipated Eligible Organizations Public/State Controlled Institution Higher Education Private Institution Higher Education Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Nonprofit without 501(c)(3) IRS Status than Institution Higher Education) Small Business For-Profit Organization than Small Business) State Government Indian/Native American Tribal Government Federally Recognized) County governments City township governments Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) Indian/Native American Tribal Government than Federally Recognized) Regional Organization Applications not being solicited this time. Inquiries Please direct inquiries to: Betty Tai, Ph.D. NIDA Center Clinical Trials Network CCTN) 301-443-2397
Grant Taxonomy: